“Retreatment With Brodalumab Results in Skin Clearance and Improvements in Quality of Life in Patients With Psoriasis After Treatment Interruption”, J of Skin, vol. 5, no. 6, p. s50, Nov. 2021, doi: 10.25251/skin.5.supp.50.